Author:
Günther Gunar,Mhuulu Lusia,Diergaardt Azaria,Dreyer Viola,Moses Maria,Anyolo Kaarna,Ruswa Nunurai,Claassens Mareli,Niemann Stefan,Nepolo Emmanuel
Publisher
Centers for Disease Control and Prevention (CDC)
Reference12 articles.
1. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment—drug-resistant tuberculosis treatment, 2022 update. Geneva: The Organization; 2022.
2. Therapeutic failure and acquired bedaquiline and delamanid resistance in treatment of drug-resistant TB.;Millard;Emerg Infect Dis,2023
3. Barilar I, Fernando T, Utpatel C, Abujate C, Madeira CM, José B, Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study. Lancet Infect Dis. 2023;S1473-3099(23)00498-X; [Epub ahead of print].
4. Evidence-based definition for extensively drug-resistant tuberculosis.;Roelens;Am J Respir Crit Care Med,2021
5. Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis.;Perumal;Eur Respir J,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献